BRAF and colorectal carcinoma: The prognostic role on RFS could not be elucidated in the meta-analysis because of limited data.<h4>Conclusions</h4>BRAF mutation was significantly related with shorter DFS and OS among stage II/III CRC patients receiving adjuvant chemotherapy after curative resection.